LATS1 and triple-negative breast carcinoma: Next, we further assessed the role of Fonti-Warts by taking human LATS1 as a control in MDA-MB-231, a human triple negative breast cancer cell line with the impaired Hippo signaling activity due to NF2 deficiency45 (Fig. 3A).